Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer(2022 edition)  

作　　者：Jianchun Duan Wenfeng Fang Hairong Xu Jinliang Wang Yuan Chen Yi Ding Xiaorong Dong Yun Fan Beili Gao Jie Hu Yan Huang Cheng Huang Dingzhi Huang Wenhua Liang Lizhu Lin Hui Liu Zhiyong Ma Meiqi Shi Yong Song Chuanhao Tang Jialei Wang Lifeng Wang Yongfeng Wang Zhehai Wang Nong Yang Yu Yao Yan Yu Qitao Yu Hongmei Zhang Jun Zhao Mingfang Zhao Zhengfei Zhu Xiaohui Niu Li Zhang Jie Wang 

机构地区：[1]CAMS Key Laboratory of Translational Research on Lung Cancer,State Key Laboratory of Molecular Oncology,Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing,China [2]Department of Respiratory Medicine,Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan,China [3]Department of Medical Oncology,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China [4]Department of Orthopaedic Oncology Surgery,Beijing Jishuitan Hospital,Capital Medical University,Beijing,China [5]Department of Oncology and Institute of Translational Medicine,Medical Innovation Research Center and the Fifth Medical Center,Chinese PLA General Hospital,Beijing,China [6]Department of Oncology,Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China [7]Cancer Center,Union Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China [8]Department of Thoracic Medical Oncology,The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,China [9]Department of Thoracic Oncology,Zhejiang Cancer Hospital,Hangzhou,China [10]Department of Respiratory Medicine,Zhongshan Hospital,Fudan University,Shanghai,China [11]Department of Medical Oncology,Fujian Cancer Hospital,Fuzhou,China [12]Department of Thoracic Medical Oncology,Lung Cancer Diagnosis and Treatment Centre,Key Laboratory of Cancer Prevention and Therapy,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Centre for Cancer,Tianjin,China [13]Department of Thoracic Surgery/Oncology,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou Institute of Respiratory Disease&Health,Guangzhou,Chi

出　　处：《Journal of the National Cancer Center》2023年第4期256-265,共10页癌症科学进展（英文）

摘　　要：Lung cancer is the leading cause of cancer-related deaths worldwide.Bone is a common metastatic site of lung cancer,about 50%of bone metastatic patients will experience skeletal related events(SREs).SREs not only seriously impact the quality of life of patients,but also shorten their survival time.The treatment of bone metastasis requires multi-disciplinary therapy(MDT)and development of individualized treatment plan.In order to standardize the diagnosis and treatment of bone metastasis in lung cancer,the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

关 键 词：Lung cancer Bone metastasis Multi-disciplinary therapy Bone-modifying drugs 

分 类 号：R73[医药卫生—肿瘤]